Close Menu X
Kelley & Ferraro, LLP
Free Consultations ~ Practicing Nationwide
216-202-3450 800-398-1795

Complaints of drug injuries from Xarelto continue to rise

Pharmaceutical liability lawsuits, much like medical malpractice cases, are difficult to navigate. Nevertheless, local attorneys in the Cleveland area with experience in pharmaceutical litigation can help Ohio victims who have suffered drug injuries from dangerous prescription medications and counsel could make all the difference. This knowledge could come in handy in light of recent developments in the ongoing series of lawsuits in various states involving the drug Xarelto.

In 2011, the Food and Drug Administration approved Xarelto as a medication to prevent blood clots in patients who suffer from atrial fibrillation, a rhythmic disorder of the heart. Blood clots can lead to pulmonary embolisms, heart attacks and strokes, and Xarelto thins the blood to stop clots from forming. Unfortunately, a common side effect is a greatly increased risk of internal bleeding, especially cranially and gastrointestinally.

The myriad of complaints against the drug's manufacturer, Bayer and Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) all allege that the company failed to provide adequate warnings of these risks. Accusations have included strict liability and negligence, failure to warn, design and manufacturing defects, fraud, breach of express and implied warranty, and more. Frighteningly, the list of victims across the country continues to grow almost daily.

The good news is that injured plaintiffs are beginning to see positive results. A recent successfully litigated Xarelto lawsuit awarded damages that reached almost $28 million. This bodes well for the thousands of other victims still hoping to see some justice for the drug injuries they have suffered. Anyone in Ohio who has similarly been injured due to Xarelto or any other prescription medications may wish to seek out the counsel of a knowledgeable lawyer who can offer guidance on how best to proceed.

Source:, "On day Philadelphia's 'Hellhole' status debated, jury hands first win to a Xarelto plaintiff - a whopping $28M", Nicholas Malfitano, Dec. 7, 2017

No Comments

Leave a comment
Comment Information

Awards & Recognition

Contact Us For A Free Case Evaluation

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

Email Us For A Response